See also this year's filing and all EDGAR filings for this company.
PDF Report 0001396814_2019_Pacira_Biosciences_Inc.pdf
Logs
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': inf, 'aggregate_val': 421026000, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}} |
Graph
Absolute values for 0001396814, Pacira Biosciences Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 477,969,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 62,040,000 |
| 2 | PropertyPlantAndEquipmentNet | 108,670,000 |
| 3 | remainder_Assets | 40,674,000 |
| 4 | LiabilitiesCurrent | 60,661,000 |
| 5 | LiabilitiesNoncurrent | 16,874,000 |
| 6 | remainder_Liabilities | 290,592,000 |
| 7 | CostOfGoodsAndServicesSold | 86,845,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 177,265,000 |
| 9 | ResearchAndDevelopmentExpense | 55,688,000 |
| 10 | remainder_Expenses | 1,610,000 |
| 11 | remainder_Revenues | 337,277,000 |
| 12 | remainder_NetIncome | -16,340,000 |
| 13 | remainder_ComprehensiveNetIncome | 174,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 689,353,000 |
| 1 | Liabilities | 368,127,000 |
| 2 | Expenses | 321,408,000 |
| 3 | Revenues | 337,277,000 |
| 4 | StockholdersEquity | 321,226,000 |
| 5 | NetIncome | -471,000 |
| 6 | ComprehensiveNetIncome | -384,000 |
| 7 | BaseVar | 866,339,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.32 |
| 9 | EconomicCapitalRatio | 2.55 |